Table 2 Clinical management and outcome of children with respiratory symptoms not admitted to hospital, before and after the intervention

Management and outcome

Before

After

p-value

Hospital admission

102 (7.9)

14 (8.4)

0.76

Discharged home

N = 1188

N = 152

Phone call contact

 Day 4

901 (75.8)

150 (98.7)

 < 0.001

 Day 8

788 (66.3)

149 (98.0)

 < 0.001

Antibiotic treatment

556 (46.8)

54 (35.5)

0.009

 Amoxicillin

74 (13.3)

4 (7.4)

0.29

 Amoxicillin/clavulanate

247 (44.4)

25 (46.3)

0.89

 Cefuroxime

92 (16.5)

15 (27.7)

0.06

 Macrolide

110 (19.8)

9 (16.7)

0.72

 Amoxicillin + macrolide

1 (0.2)

0

-

 Amoxicillin/clavulanate + macrolide

25 (4.6)

0

-

 Cefuroxime + macrolide

6 (1.0)

0

-

 Clindamycin

1 (0.2)

0

-

 Cephalexin

0

1 (1.9)

-

Antibiotic treatment by age group

 12–23 months

322 (57.9)

29 (53.6)

0.57

 24–59 months

234 (42.1)

25 (46.4)

Representation within 1 week

N = 141 (11.9)

N = 10 (6.6)

0.10

Reason revisit

 Prolonged cough

42 (29.8)

0

-

 High fever^a

33 (23.4)

7 (70.0)

0.004

 Cough and fever

14 (9.9)

1 (10.0)

-

 Breathlessness

4 (2.9)

1 (10.0)

-

 Prolonged runny nose

2 (1.3)

0

-

 Routine follow up by physician

19 (13.5)

1 (10.0)

-

 Other

27 (19.2)

0

-

Diagnosis at representation

 Pneumonia

45 (31.9)

1 (10.0)

 Asthma

7 (5.0)

2 (20.0)

-

 Bronchiolitis

6 (4.3)

0

-

 Bronchitis

8 (5.7)

0

-

 URTI

58 (41.1)

2 (20.0)

-

 Others (viral infections)

17 (12.0)

5 (50.0)

-

Antibiotic treatment at representation

70 (49.6)

2 (20.0)

 Macrolide

8 (11.4)

1 (50)

-

 Cefuroxime

13 (18.6)

1 (50)

-

 Amoxicillin

1 (1.4)

0

-

 Amoxicillin/clavulanate

38 (5.3)

0

-

 Amoxicillin/clavulanate + macrolide

6 (8.6)

0

-

 Cefuroxime + macrolide

4 (5.7)

0

-

Hospital admission at representation

N = 25 (17.7)

N = 3 (30.0)

0.40

 Admitted to DHWC

18 (72.0)

2 (66.7)

1.00

 Admitted to another hospital

7 (28.0)

1 (33.3)

-